Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: A clinical and microbiological study

Giuseppe Morelli, Sandra Mazzoli, Enrico Tortoli, M. Tullia Simonetti, Francesco Perruna, Attilio Postiglione

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

The purpose of this study was to evaluate the efficacy and safety of five fluoroquinolones: ofloxacin, pefloxacin, ciprofloxacin, enoxacin, and norfloxacin, when compared with chloramphenicol in the therapy of typhoid fever. One hundred fifty-six patients suffering from Salmonella typhi infection entered this open study. They were divided into six groups and randomly assigned. A wide microbiologic study was conducted to support the thesis that isolates of S typhi showing identical serological and biochemical characteristics, were a single clone, as a recent genetic work has proven. At the conclusion of treatment, the enoxacin and norfloxacin groups reported some nonresponders and patients with chronic enteric carrier state. Ofloxacin and ciprofloxacin were more effective than chloramphenicol. No relapses or chronic enteric carrier states were reported in these two groups or the pefloxacin group but ofloxacin was more effective, with milder side effects.

Original languageEnglish
Pages (from-to)532-542
Number of pages11
JournalCurrent Therapeutic Research
Volume52
Issue number4
DOIs
Publication statusPublished - 1992

Fingerprint

Ofloxacin
Typhoid Fever
Fluoroquinolones
Chloramphenicol
Enoxacin
Pefloxacin
Carrier State
Norfloxacin
Ciprofloxacin
Salmonella typhi
Salmonella Infections
Therapeutics
Clone Cells
Safety
Recurrence
Clinical Studies

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever : A clinical and microbiological study. / Morelli, Giuseppe; Mazzoli, Sandra; Tortoli, Enrico; Tullia Simonetti, M.; Perruna, Francesco; Postiglione, Attilio.

In: Current Therapeutic Research, Vol. 52, No. 4, 1992, p. 532-542.

Research output: Contribution to journalArticle

Morelli, G, Mazzoli, S, Tortoli, E, Tullia Simonetti, M, Perruna, F & Postiglione, A 1992, 'Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: A clinical and microbiological study', Current Therapeutic Research, vol. 52, no. 4, pp. 532-542. https://doi.org/10.1016/S0011-393X(05)80459-X
Morelli, Giuseppe ; Mazzoli, Sandra ; Tortoli, Enrico ; Tullia Simonetti, M. ; Perruna, Francesco ; Postiglione, Attilio. / Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever : A clinical and microbiological study. In: Current Therapeutic Research. 1992 ; Vol. 52, No. 4. pp. 532-542.
@article{e652c855d8294c8b9d459931e789a6f1,
title = "Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever: A clinical and microbiological study",
abstract = "The purpose of this study was to evaluate the efficacy and safety of five fluoroquinolones: ofloxacin, pefloxacin, ciprofloxacin, enoxacin, and norfloxacin, when compared with chloramphenicol in the therapy of typhoid fever. One hundred fifty-six patients suffering from Salmonella typhi infection entered this open study. They were divided into six groups and randomly assigned. A wide microbiologic study was conducted to support the thesis that isolates of S typhi showing identical serological and biochemical characteristics, were a single clone, as a recent genetic work has proven. At the conclusion of treatment, the enoxacin and norfloxacin groups reported some nonresponders and patients with chronic enteric carrier state. Ofloxacin and ciprofloxacin were more effective than chloramphenicol. No relapses or chronic enteric carrier states were reported in these two groups or the pefloxacin group but ofloxacin was more effective, with milder side effects.",
author = "Giuseppe Morelli and Sandra Mazzoli and Enrico Tortoli and {Tullia Simonetti}, M. and Francesco Perruna and Attilio Postiglione",
year = "1992",
doi = "10.1016/S0011-393X(05)80459-X",
language = "English",
volume = "52",
pages = "532--542",
journal = "Current Therapeutic Research - Clinical and Experimental",
issn = "0011-393X",
publisher = "Excerpta Medica",
number = "4",

}

TY - JOUR

T1 - Fluoroquinolones versus chloramphenicol in the therapy of typhoid fever

T2 - A clinical and microbiological study

AU - Morelli, Giuseppe

AU - Mazzoli, Sandra

AU - Tortoli, Enrico

AU - Tullia Simonetti, M.

AU - Perruna, Francesco

AU - Postiglione, Attilio

PY - 1992

Y1 - 1992

N2 - The purpose of this study was to evaluate the efficacy and safety of five fluoroquinolones: ofloxacin, pefloxacin, ciprofloxacin, enoxacin, and norfloxacin, when compared with chloramphenicol in the therapy of typhoid fever. One hundred fifty-six patients suffering from Salmonella typhi infection entered this open study. They were divided into six groups and randomly assigned. A wide microbiologic study was conducted to support the thesis that isolates of S typhi showing identical serological and biochemical characteristics, were a single clone, as a recent genetic work has proven. At the conclusion of treatment, the enoxacin and norfloxacin groups reported some nonresponders and patients with chronic enteric carrier state. Ofloxacin and ciprofloxacin were more effective than chloramphenicol. No relapses or chronic enteric carrier states were reported in these two groups or the pefloxacin group but ofloxacin was more effective, with milder side effects.

AB - The purpose of this study was to evaluate the efficacy and safety of five fluoroquinolones: ofloxacin, pefloxacin, ciprofloxacin, enoxacin, and norfloxacin, when compared with chloramphenicol in the therapy of typhoid fever. One hundred fifty-six patients suffering from Salmonella typhi infection entered this open study. They were divided into six groups and randomly assigned. A wide microbiologic study was conducted to support the thesis that isolates of S typhi showing identical serological and biochemical characteristics, were a single clone, as a recent genetic work has proven. At the conclusion of treatment, the enoxacin and norfloxacin groups reported some nonresponders and patients with chronic enteric carrier state. Ofloxacin and ciprofloxacin were more effective than chloramphenicol. No relapses or chronic enteric carrier states were reported in these two groups or the pefloxacin group but ofloxacin was more effective, with milder side effects.

UR - http://www.scopus.com/inward/record.url?scp=0026660597&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026660597&partnerID=8YFLogxK

U2 - 10.1016/S0011-393X(05)80459-X

DO - 10.1016/S0011-393X(05)80459-X

M3 - Article

AN - SCOPUS:0026660597

VL - 52

SP - 532

EP - 542

JO - Current Therapeutic Research - Clinical and Experimental

JF - Current Therapeutic Research - Clinical and Experimental

SN - 0011-393X

IS - 4

ER -